Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice. Issue 3 (8th January 2022)
- Record Type:
- Journal Article
- Title:
- Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice. Issue 3 (8th January 2022)
- Main Title:
- Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice
- Authors:
- Calvet‐Mirabent, Marta
Claiborne, Daniel T.
Deruaz, Maud
Tanno, Serah
Serra, Carla
Delgado‐Arévalo, Cristina
Sánchez‐Cerrillo, Ildefonso
de los Santos, Ignacio
Sanz, Jesús
García‐Fraile, Lucio
Sánchez‐Madrid, Francisco
Alfranca, Arantzazu
Muñoz‐Fernández, María Ángeles
Allen, Todd M.
Buzón, Maria J.
Balazs, Alejandro
Vrbanac, Vladimir
Martín‐Gayo, Enrique - Abstract:
- Abstract: Effective function of CD8 + T cells and enhanced innate activation of DCs in response to HIV‐1 is linked to protective antiviral immunity in controllers. Manipulation of DC targeting the master regulator TANK‐binding Kinase 1 (TBK1) might be useful to acquire controller‐like properties. Here, we evaluated the impact of the combination of 2´3´‐c´diAM(PS)2 and Poly I:C as potential adjuvants capable of potentiating DC´s abilities to induce polyfunctional HIV‐1 specific CD8 + T‐cell responses in vitro and in vivo using a humanized BLT mouse model. Adjuvant combination enhanced TBK‐1 phosphorylation and IL‐12 and IFN‐β expression on DC and increased their ability to activate polyfunctional HIV‐1‐specific CD8 + T cells in vitro . Moreover, higher proportions of hBLT mice vaccinated with ADJ‐DC exhibited less severe CD4 + T‐cell depletion following HIV‐1 infection compared to control groups. This was associated with infiltration of CD8 + T cells in the white pulp from the spleen, reduced spread of infected p24 + cells to LN, and with preserved abilities of CD8 + T cells from the spleen and blood of vaccinated animals to induce specific polyfunctional responses upon antigen stimulation. Therefore, priming of DC with PolyI:C and STING agonists might be useful for future HIV‐1 vaccine studies. Abstract : Vaccination of humanized BLT mice with DCs primed with 2'3'‐c'diAM(PS)2 and Poly I:C increased infiltration and polyfunctionality of HIV‐1‐specific CD8+ T cells into theAbstract: Effective function of CD8 + T cells and enhanced innate activation of DCs in response to HIV‐1 is linked to protective antiviral immunity in controllers. Manipulation of DC targeting the master regulator TANK‐binding Kinase 1 (TBK1) might be useful to acquire controller‐like properties. Here, we evaluated the impact of the combination of 2´3´‐c´diAM(PS)2 and Poly I:C as potential adjuvants capable of potentiating DC´s abilities to induce polyfunctional HIV‐1 specific CD8 + T‐cell responses in vitro and in vivo using a humanized BLT mouse model. Adjuvant combination enhanced TBK‐1 phosphorylation and IL‐12 and IFN‐β expression on DC and increased their ability to activate polyfunctional HIV‐1‐specific CD8 + T cells in vitro . Moreover, higher proportions of hBLT mice vaccinated with ADJ‐DC exhibited less severe CD4 + T‐cell depletion following HIV‐1 infection compared to control groups. This was associated with infiltration of CD8 + T cells in the white pulp from the spleen, reduced spread of infected p24 + cells to LN, and with preserved abilities of CD8 + T cells from the spleen and blood of vaccinated animals to induce specific polyfunctional responses upon antigen stimulation. Therefore, priming of DC with PolyI:C and STING agonists might be useful for future HIV‐1 vaccine studies. Abstract : Vaccination of humanized BLT mice with DCs primed with 2'3'‐c'diAM(PS)2 and Poly I:C increased infiltration and polyfunctionality of HIV‐1‐specific CD8+ T cells into the spleen white pulp, reduced spread of infection to the LN, and less severe CD4+ T‐cell depletion after HIV‐1 infection. … (more)
- Is Part Of:
- European journal of immunology. Volume 52:Issue 3(2022)
- Journal:
- European journal of immunology
- Issue:
- Volume 52:Issue 3(2022)
- Issue Display:
- Volume 52, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 3
- Issue Sort Value:
- 2022-0052-0003-0000
- Page Start:
- 447
- Page End:
- 461
- Publication Date:
- 2022-01-08
- Subjects:
- CD8+ T cell -- dendritic cell -- hBLT mouse -- lymphoid tissue -- vaccine
Immunology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/eji.202149502 ↗
- Languages:
- English
- ISSNs:
- 0014-2980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.730100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20993.xml